Targeting selectins for the treatment of inflammatory diseases

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 1, 2014, Pages 55-67

  Impellizzeri, Daniela ^a   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cytokines; Inflammation; Leukocyte; Selectins; Targets

Indexed keywords

ASELIZUMAB; BIMOSIAMOSE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; L SELECTIN; LIGAND; PADGEM PROTEIN; SELECTIN;

ALZHEIMER DISEASE; ASTHMA; BRAIN ISCHEMIA; CANCER GROWTH; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DRUG TARGETING; ENTERITIS; HUMAN; INFLAMMATION; LEUKOCYTE ROLLING; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REVIEW;

ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; SELECTINS;

EID: 84890354296     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.841140     Document Type: Review

References (100)

1. Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 2002;82:521-33
2. Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-89
3. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-14
4. Marshall D, Haskard DO. Clinical overview of leukocyte adhesion and migration: Where are we now? Semin Immunol 2002;14:133-40
5. Varki A, Varki NM. P-selectin, carcinoma metastasis and heparin: Novel mechanistic connections with therapeutic implications. Braz J Med Biol Res 2001;34:711-17
6. Ulbrich H, Eriksson EE, Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 2003;24:640-7
7. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: Present and future therapeutic targets. Nat Immunol 2005;6:1182-90
8. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-6
9. Feizi T. Carbohydrate ligands for the leukocyte-endothelium adhesion molecules, selectins. Results Probl Cell Differ 2001;33:201-23
10. Ley K. Functions of selectins. Results Probl Cell Differ 2001;33:177-200
11. Kneuer C, Ehrhardt C, Radomski MW, et al. Selectins-potential pharmacological targets? Drug Discov Today 2006;11:1034-40
12. Ehrhardt C, Kneuer C, Bakowsky U. Selectins-An emerging target for drug delivery. Adv Drug Deliv Rev 2004;56:527-49
13. McEver RP, Beckstead JH, Moore KL, et al. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989;84:92-9
14. Pan J, Xia L, McEver RP. Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. J Biol Chem 1998;273:10058-67
15. Impellizzeri D, Mazzon E, Di Paola R, et al. Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice. Free Radic Res 2011;45:820-34
16. Essani NA, McGuire GM, Manning AM, et al. Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 1996;156:2956-63
17. Koenig A, Jain R, Vig R, et al. Selectin inhibition: Synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. Glycobiology 1997;7:79-93
18. Dube DH, Bertozzi CR. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov 2005;4:477-88
19. Hennet T. The galactosyltransferase family. Cell Mol Life Sci 2002;59:1081-95
20. de Vries T, Knegtel RM, Holmes EH, et al. Fucosyltransferases: Structure/ function studies. Glycobiology 2001;11:119R-28R
21. Cummings RD. Structure and function of the selectin ligand PSGL-1. Braz J Med Biol Res 1999;32:519-28
22. Bullard DC, Qin L, Lorenzo I, et al. P-selectin/ICAM-1 double mutant mice: Acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest 1995;95:1782-8
23. Sperandio M, Smith ML, Forlow SB, et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med 2003;197:1355-63
24. Hidalgo A, Peired AJ, Wild MK, et al. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 2007;26:477-89
25. Nandi A, Estess P, Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 2004;20:455-65
26. Rosen SD. Ligands for L-selectin: Where and how many? Res Immunol 1993;144:699-703
27. Sassetti C, Tangemann K, Singer MS, et al. Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: Parallels to CD34. J Exp Med 1998;187:1965-75
28. Barthel SR, Gavino JD, Descheny L, et al. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 2007;11:1473-91
29. Eppihimer MJ, Schaub RG. Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules. Microcirculation 2001;8:15-24
30. Sako D, Comess KM, Barone KM, et al. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 1995;83:323-31
31. Hayward R, Campbell B, Shin YK, et al. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res 1999;41:65-76
32. Kyriakides C, Austen W Jr, Wang Y, et al. Endothelial selectin blockade attenuates lung permeability of experimental acid aspiration. Surgery 2000;128:327-31
33. Hicks AE, Nolan SL, Ridger VC, et al. Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: Complete inhibition of rolling is not required for anti-inflammatory effect. Blood 2003;101:3249-56
34. Bannert N, Craig S, Farzan M, et al. Sialylated O-glycans and sulfated tyrosines in the NH2-Terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J Exp Med 2001;194:1661-73
35. Veerman KM, Williams MJ, Uchimura K, et al. Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs. Nat Immunol 2007;8:532-9
36. Snapp KR, Wagers AJ, Craig R, et al. P-selectin glycoprotein ligand-1 is essential for adhesion to P-selectin but not E-selectin in stably transfected hematopoietic cell lines. Blood 1997;89:896-901
37. Mitchell ML, Tian F, Lee LV, Wong CH. Synthesis and evaluation of transition-state analogue inhibitors of alpha-1,3-fucosyltransferase. Angew Chem Int Ed Engl 2002;41:3041-4
38. Maly P, Thall A, Petryniak B, et al. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996;86:643-53
39. Miura Y, Kim S, Etchison JR, et al. Aglycone structure influences alpha-fucosyltransferase III activity using N-Acetyllactosamine glycoside acceptors. Glycoconj J 1999;16:725-30
40. Lee LV, Mitchell ML, Huang SJ, et al. A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry. J Am Chem Soc 2003;125:9588-9
41. Bryan MC, Lee LV, Wong CH. High-Throughput identification of fucosyltransferase inhibitors using carbohydrate microarrays. Bioorg Med Chem Lett 2004;14:3185-8
42. Bengtson P, Lundblad A, Larson G, et al. Polymorphonuclear leukocytes from individuals carrying the G329A mutation in the alpha 1,3-fucosyltransferase VII gene (FUT7) roll on E- And P-selectins. J Immunol 2002;169:3940-6
43. Dimitroff CJ, Bernacki RJ, Sackstein R. Glycosylation-dependent inhibition of cutaneous lymphocyte-Associated antigen expression: Implications in modulating lymphocyte migration to skin. Blood 2003;101:602-10
44. Descheny L, Gainers ME, Walcheck B, et al. Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of N-Acetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand. J Invest Dermatol 2006;126:2065-73
45. Dimitroff CJ, Kupper TS, Sackstein R. Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-Associated antigen. J Clin Invest 2003;112:1008-18
46. Spevak W, Foxall C, Charych DH, et al. Carbohydrates in an acidic multivalent assembly: Nanomolar P-selectin inhibitors. J Med Chem 1996;39:1018-20
47. Cappi MW, Moree WJ, Qiao L, et al. Synthesis of novel 6-Amido-6-deoxy-lgalactose derivatives as sialyl Lewis X mimetics. Bioorg Med Chem 1997;5:283-96
48. Murohara T, Margiotta J, Phillips LM, et al. Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury. Cardiovasc Res 1995;30:965-74
49. Friedrich M, Bock D, Philipp S, et al. Pan-selectin antagonism improves psoriasis manifestation in mice and man. Arch Dermatol Res 2006;297:345-51
50. Schon MP, Krahn T, Schon M, et al. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med 2002;8:366-72
51. Ludwig RJ, Alban S, Bistrian R, et al. The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb Haemost 2006;95:535-40
52. Sarkar AK, Brown JR, Esko JD. Synthesis and glycan priming activity of acetylated disaccharides. Carbohydr Res 2000;329:287-300
53. Ludwig RJ, Schon MP, Boehncke WH. P-selectin: A common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther Targets 2007;11:1103-17
54. Fuhlbrigge RC, Weishaupt C. Adhesion molecules in cutaneous immunity. Semin Immunopathol 2007;29:45-57
55. Davenpeck KL, Berens KL, Dixon RA, et al. Inhibition of adhesion of human neutrophils and eosinophils to P-selectin by the sialyl Lewis antagonist TBC1269: Preferential activity against neutrophil adhesion in vitro. J Allergy Clin Immunol 2000;105:769-75
56. Hicks AE, Abbitt KB, Dodd P, et al. The anti-inflammatory effects of a selectin ligand mimetic, TBC-1269, are not a result of competitive inhibition of leukocyte rolling in vivo. J Leukoc Biol 2005;77:59-66
57. Beeh KM, Beier J, Meyer M, et al. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: A randomized, double-blind, placebo-controlled clinical cross-over-Trial. Pulm Pharmacol Ther 2006;19:233-41
58. Avila PC, Boushey HA, Wong H, et al. Effect of a single dose of the selectin inhibitor TBC1269 on early and late asthmatic responses. Clin Exp Allergy 2004;34:77-84
59. Schlag G, Redl HR, Till GO, et al. Anti-L-selectin antibody treatment of hemorrhagic-Traumatic shock in baboons. Crit Care Med 1999;27:1900-7
60. Seekamp A, van Griensven M, Dhondt E, et al. The effect of anti-L-selectin (aselizumab) in multiple traumatized patients-results of a phase II clinical trial. Crit Care Med 2004;32:2021-8
61. Rosen SD, Tsay D, Singer MS, et al. Therapeutic targeting of endothelial ligands for L-selectin (PNAd) in a sheep model of asthma. Am J Pathol 2005;166:935-44
62. Rossi B, Angiari S, Zenaro E, et al. Vascular inflammation in central nervous system diseases: Adhesion receptors controlling leukocyte-endothelial interactions. J Leukoc Biol 2011;89:539-56
63. Mayadas TN, Johnson RC, Rayburn H, et al. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993;74:541-54
64. Labow MA, Norton CR, Rumberger JM, et al. Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins. Immunity 1994;1:709-20
65. Mulligan MS, Paulson JC, De Frees S, et al. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 1993;364:149-51
66. Bullard DC, Kunkel EJ, Kubo H, et al. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med 1996;183:2329-36
67. Frenette PS, Mayadas TN, Rayburn H, et al. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- And E-selectins. Cell 1996;84:563-74
68. Forlow SB, White EJ, Thomas KL, et al. T cell requirement for development of chronic ulcerative dermatitis in E- And P-selectin-deficient mice. J Immunol 2002;169:4797-804
69. Subramaniam M, Frenette PS, Saffaripour S, et al. Defects in hemostasis in P-selectin-deficient mice. Blood 1996;87:1238-42
70. Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 1996;79:1196-204
71. Singbartl K, Ley K. Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med 2000;28:2507-14
72. Rauchhaus M, Gross M, Schulz S, et al. The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. Int J Cardiol 2002;83:249-57
73. Lukacs NW, John A, Berlin A, et al. Eand P-selectins are essential for the development of cockroach allergen-induced airway responses. J Immunol 2002;169:2120-5
74. Mandalari G, Bisignano C, Genovese T, et al. Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease. Int Immunopharmacol 2011;11:915-24
75. Panes J. Inflammatory bowel disease: Pathogenesis and targets for therapeutic interventions. Acta Physiol Scand 2001;173:159-65
76. Sans M, Salas A, Soriano A, et al. Differential role of selectins in experimental colitis. Gastroenterology 2001;120:1162-72
77. Bhatti M, Chapman P, Peters M, et al. Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut 1998;43:40-7
78. Fuster V, Poon M, Willerson JT. Learning from the transgenic mouse: Endothelium, adhesive molecules, and neointimal formation. Circulation 1998;97:16-18
79. Ishiwata S, Tukada T, Nakanishi S, et al. Postangioplasty restenosis: Platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J 1997;133:387-92
80. Tenaglia AN, Buda AJ, Wilkins RG, et al. Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris. Am J Cardiol 1997;79:742-7
81. Kumar A, Hoover JL, Simmons CA, et al. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation 1997;96:4333-42
82. Hayashi S, Watanabe N, Nakazawa K, et al. Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries. Circulation 2000;102:1710-17
83. Myers DD, Rectenwald JE, Bedard PW, et al. Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg 2005;42:329-36
84. Gutsaeva DR, Parkerson JB, Yerigenahally SD, et al. Inhibition of cell adhesion by anti-P-selectin aptamer: A new potential therapeutic agent for sickle cell disease. Blood 2011;117:727-35
85. Mulligan MS, Miyasaka M, Ward PA. Protective effects of combined adhesion molecule blockade in models of acute lung injury. Proc Assoc Am Physicians 1996;108:198-208
86. Serrano-Mollar A, Closa D, Cortijo J, et al. P-selectin upregulation in bleomycin induced lung injury in rats: Effect of N-Acetyl-L-cysteine. Thorax 2002;57:629-34
87. Clark RA, Chong B, Mirchandani N, et al. The vast majority of CLA+ T cells are resident in normal skin. J Immunol 2006;176:4431-9
88. Steeber DA, Tang ML, Green NE, et al. Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J Immunol 1999;163:2176-86
89. Shimada Y, Hasegawa M, Kaburagi Y, et al. L-selectin or ICAM-1 deficiency reduces an immediate-Type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity. J Immunol 2003;170:4325-34
90. Kaburagi Y, Hasegawa M, Nagaoka T, et al. The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression. J Immunol 2002;168:2970-8
91. Nagaoka T, Kaburagi Y, Hamaguchi Y, et al. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 2000;157:237-47
92. Laubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol 2010;20:169-77
93. Bendas G, Borsig L. Cancer cell adhesion and metastasis: Selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol 2012;2012:676731
94. Laubli H, Spanaus KS, Borsig L. Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. Blood 2009;114:4583-91
95. Hiratsuka S, Goel S, Kamoun WS, et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci USA 2011;108:3725-30
96. Hiller KM, Mayben JP, Bendt KM, et al. Transfection of alpha(1,3) fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol Carcinog 2000;27:280-8
97. Lin E, Calvano SE, Lowry SF. Selectin neutralization: Does it make biological sense? Crit Care Med 1999;27:2050-3
98. Jung U, Ley K. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J Immunol 1999;162:6755-62
99. Schon MP. Inhibitors of selectin functions in the treatment of inflammatory skin disorders. Ther Clin Risk Manag 2005;1:201-8
100. Zollner TM, Podda M, Pien C, et al. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. J Clin Invest 2002;109:671-9